Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative High Protein vs Immunoenhancing ONS in GI Cancer
NCT03980704Phase 4Completed
- Sponsor
- Stanley Dudrick Memorial Hospital
- Start
- Apr 2019
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Phase 4, randomised trial (2 arms), sponsored by Stanley Dudrick Memorial Hospital. Primary endpoint: Infectious complications at 6 months. Started Apr 2019; status: completed.
Beyond the preview
Go deeper on NCT03980704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03980704.